Texas First for Epioxa Therapy

The first US rollout of FDA-approved epi-on cross-linking aims to improve comfort and recovery for keratoconus patients

May 6, 2026
2 min

The Ophthalmologist

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

#1

Hospital Universitario 12 de Octubre

Madrid, Spain
Key Differentiators
- Neurology
#2

The Eye Center of Texas

Houston, Texas
Key Differentiators
- Ophthalmology
- Neurology
#3

Atlantic Health

Morristown, New Jersey
Key Differentiators
- Neurology
#4

Overlook Medical Center

Summit, New Jersey
Key Differentiators
- Neurology
#5

Morristown Medical Center

Morristown, New Jersey
Key Differentiators
- Neurology

Original Source(s)

The Ophthalmologist

Texas First for Epioxa Therapy

May 6, 2026

Related Content

Ophthalmology Management

Corneal Crosslinking Reimbursement<br>In Its Tenth Year

Providing crosslinking procedures in an ophthalmology practice is not for the faint of heart. Ultimately, despite its clinical importance, offering crosslinking remains financially challenging for many practices.

by Laurie Brown, MBA, COMT, COE, CPC, CPMA, LSSYB, Brittney Irwin, COT, CPC, CEP
January 1, 2026
5 min

Ophthalmology Management

A Transformative Period

Cornea, cataract, refractive, and anterior segment surgery remain at the forefront of ophthalmic innovation, yet several challenges persist that demand critical reflection and collaborative solutions. As we navigate 2025, a few key issues warrant our attention.